ovarian cancer australia symposium 2016 professor jonathan lederman on parp inhibitors.
Published 7 years ago • 191 plays • Length 47:41Download video MP4
Download video MP3
Similar videos
-
34:36
parp inhibitors with johnathan lederman
-
4:06
the promise of parp inhibitors and their emerging role in ovarian cancer
-
1:00:06
webinar: parp inhibitors and ovarian cancer
-
25:31
webinar: parp inhibitors and ovarian cancer with kristen young
-
2:15
toxicities associated with rucaparib for the treatment of ovarian cancer
-
2:15:30
ovarian cancer symposium 2021: session 4 parp inhibitors
-
7:10
jonathan a ledermann – maintenance treatment for recurrent ovarian carcinoma
-
1:57
dr. ledermann on parp inhibitors in maintenance therapy for ovarian cancer
-
1:20
dr. ledermann discusses olaparib in ovarian cancer
-
3:09
the promising potential of parp inhibitors in ovarian cancer
-
1:19
dr. ledermann on phase iii ariel3 results in ovarian cancer
-
58:46
learn all about parp inhibitors with dr jon krell, consultant medical oncologist
-
5:51
prof jonathan ledermann
-
1:42
phase iii results for rucaparib in ovarian cancer
-
1:14
dr. ledermann on the treatment landscape for rare gynecologic cancers
-
0:58
dr. ledermann on systemic treatment for rare gynecologic tumors
-
3:58
the potential of parp inhibitors in ovarian cancer: paola-1, prima & velia
-
5:35
parp inhibitors (jonathan a. ledermann)